Mar 29, 2013 ... J&J Wins Approval for First in New Class of Diabetes Drugs. Johnson ... “I worry
its use in women will be somewhat minimal,” Butler said.
Mar 29, 2013 ... The approval gives the healthcare giant its first market green light for a new ...
UPDATED: J&J wins first FDA approval for new class of diabetes drug ... with a
relatively high rate of genital infections which will limit uptake in our ...
Apr 1, 2013 ... And J&J ($JNJ) will have to spend a pretty penny on detailing and advertising to
... And it's true that diabetes patients often have to change meds to keep control of
... J&J wins first FDA approval for new class of diabetes drug
Apr 5, 2013 ... The FDA has approved Invokana (canagliflozin), the first drug in a new class of ...
As the first company to win FDA approval, Johnson & Johnson has a leg up on
industry rivals developing their own ... More details on the studies will be
presented at the American Diabetes Association annual meeting in June.
Apr 1, 2013 ... "Patients with type 2 diabetes struggle managing their blood sugar, and nearly
half of ... Janssen will partner with other Johnson & Johnson companies focused
on ..... (BIIB) Wins FDA Approval for Blockbuster Oral MS Drug.
Feb 4, 2016 ... Johnson & Johnson, continuing its long quest for a Type 1 diabetes cure, ... "We
wanted to hedge our bets to make sure we would win in this space ... Further
testing may be needed before the product can be approved by regulators. ....
Does anyone for a second think that ANY socialized medicine nation or ...
May 24, 2016 ... Samsung Has a Best-Selling American Drug in Its Crosshairs ... It's chasing U.S.
approval for a biosimilar of Remicade. ... And on Monday, the company said the
FDA will review the application for its biosimilar of Johnson & Johnson's ... the
Remicade biosimilar in America if it wins the FDA's blessing.
Mar 29, 2013 ... Some analysts think doctors will use the SGLT class as a last-line option ... The
FDA's approval of Invokana is a milestone for J&J because, although the ...
meters, Invokana is its first prescription drug for type 2 diabetes.
Jan 26, 2016 ... GM's $421 Million Investment Deal Wins Approval By Canadian Union ...
Healthcare conglomerate Johnson & Johnson has its growing drug sales to ...
vision care, and diabetes care, part of the same division, won't be affected by the
cuts. ... The diversified growth will be especially important as Johnson ....
The drug is the only compound approved for diabetes that does not have an ...
drugmaker Janssen Pharmaceuticals, a Johnson & Johnson company, will ... and
is contraindicated in patients who have increased ketones in their blood or urine.